Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Phosphatidylinositol 3-kinase in breast cancer: where from here?

× No keyword cloud information.

6 in total

1. PIK3CA mutations in in situ and invasive breast carcinomas.

Authors: Alexander Miron; Maria Varadi; Daniel Carrasco; Hailun Li; Lauren Luongo; Hee Jung Kim; So Yeon Park; Eun Yoon Cho; Gretchen Lewis; Sarah Kehoe; J Dirk Iglehart; Deborah Dillon; D Craig Allred; Laura Macconaill; Rebecca Gelman; Kornelia Polyak
Journal: Cancer Res Date: 2010-06-15 Impact factor: 12.701

Review 2. PI3K/PTEN signaling in angiogenesis and tumorigenesis.

Authors: Bing-Hua Jiang; Ling-Zhi Liu
Journal: Adv Cancer Res Date: 2009 Impact factor: 6.242

3. Analysing the mutational status of PIK3CA in circulating tumor cells from metastatic breast cancer patients.

Authors: Helen Schneck; Christina Blassl; Franziska Meier-Stiegen; Rui Pedro Neves; Wolfgang Janni; Tanja Fehm; Hans Neubauer
Journal: Mol Oncol Date: 2013-07-13 Impact factor: 6.603

4. PI3K expression and PIK3CA mutations are related to colorectal cancer metastases.

Authors: Yu-Fen Zhu; Bao-Hua Yu; Da-Li Li; Hong-Lin Ke; Xian-Zhi Guo; Xiu-Ying Xiao
Journal: World J Gastroenterol Date: 2012-07-28 Impact factor: 5.742

5. PIK3CA mutations frequently coexist with EGFR/KRAS mutations in non-small cell lung cancer and suggest poor prognosis in EGFR/KRAS wildtype subgroup.

Authors: Lei Wang; Haichuan Hu; Yunjian Pan; Rui Wang; Yuan Li; Lei Shen; Yongfu Yu; Hang Li; Deng Cai; Yihua Sun; Haiquan Chen
Journal: PLoS One Date: 2014-02-12 Impact factor: 3.240

Review 6. Impact of genetic alterations on mTOR-targeted cancer therapy.

Authors: Shi-Yong Sun
Journal: Chin J Cancer Date: 2013-03-15

6 in total